The Effect of Moderate-Dose Steroid Therapy in Sepsis

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2009

Conditions
Sepsis
Interventions
DRUG

Prednisolone

Soon after the presumptive diagnosis of severe sepsis, initial laboratory specimens were obtained within 2 hours, and the patients were randomized to treatment with prednisolone or placebo groups. The treatment groups were determined by a computer-generated randomization procedure (in a 1:1 ratio). The steroid group received prednisolone at a moderate-dose (20 mg/day). Prednisolone was given intravenously at 06.00 (10 mg) 14.00 (5 mg) and 22.00 (5 mg) for 10 days. The standard therapy group received a placebo infusion containing physiological saline solution in an identical manner. Patients and their primary physicians were blinded as to which therapy was administered.

All Listed Sponsors
lead

TC Erciyes University

OTHER

NCT01275638 - The Effect of Moderate-Dose Steroid Therapy in Sepsis | Biotech Hunter | Biotech Hunter